Biostorage Technologies
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
$8.3m | Series A | ||
$127m Valuation: $127m | Acquisition | ||
Total Funding | AUD12.8m |
Recent News about Biostorage Technologies
EditBioStorage Technologies, a part of Brooks Life Sciences, specializes in providing comprehensive sample management and storage solutions tailored for the biotech and pharmaceutical industries. The company offers a range of services including sample integrated lifecycle management, sample storage, sample preparation, lab analytical services, and clinical trial collection kit and project management. BioStorage Technologies operates in the global market, serving clients involved in research, clinical trials, and vaccine development. Their business model revolves around offering specialized services that ensure the safety, integrity, and regulatory compliance of biological samples, which are critical for FDA review and other regulatory bodies. The company generates revenue through service contracts with biotech and pharmaceutical companies, providing them with essential solutions for sample management and storage. Key features include biological transport, lab moving, information technology solutions, business continuity, risk mitigation planning, and quality management. BioStorage Technologies stands out for its commitment to minimizing the environmental impact of cold sample storage, optimizing energy usage, and space, which translates to better sample management and cost savings for their clients.
Keywords: sample management, storage solutions, biotech, pharmaceutical, clinical trials, regulatory compliance, biological transport, risk mitigation, quality management, vaccine development.